Literature DB >> 2686850

Cisplatin nephrotoxicity. A review.

G Daugaard1, U Abildgaard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2686850     DOI： 10.1007/bf00694330

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN： 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  88 in total

1.  Phase II study of cis-diamminedichloroplatinum (NSC-119875) in advanced carcinoma of the large bowel.

Authors:  J S Kovach; C G Moertel; A J Schutt; R G Reitemeier; R G Hahn
Journal:  Cancer Chemother Rep       Date:  1973 Sep-Oct

2.  A comparison of renal function in rats anesthetized with inactin and sodium amytal.

Authors:  M Elmer; P C Eskildsen; L O Kristensen; P P Leyssac
Journal:  Acta Physiol Scand       Date:  1972-09

3.  Cisplatin-induced hypomagnesemic hypocalcemia.

Authors:  J B Hill; A Russo
Journal:  Arch Intern Med       Date:  1981-07

4.  The renal handling of sodium and water is not affected by the standard-dose cisplatin treatment for testicular cancer.

Authors:  G Daugaard; S Strandgaard; N H Holstein-Rathlou; P L Frederiksen; U G Svendsen; O Munck; P P Leyssac
Journal:  Scand J Clin Lab Invest       Date:  1987-09       Impact factor: 1.713

5.  Magnesium homeostasis following chemotherapy with cisplatin: a prospective study.

Authors:  A F Stewart; T Keating; P E Schwartz
Journal:  Am J Obstet Gynecol       Date:  1985-11-15       Impact factor: 8.661

6.  Effect of sodium thiosulfate on cis-dichlorodiammineplatinum(II) toxicity and antitumor activity in L1210 leukemia.

Authors:  S B Howell; R Taetle
Journal:  Cancer Treat Rep       Date:  1980 Apr-May

7.  Hypomagnesemia after cisplatin combination chemotherapy.

Authors:  J E Buckley; V L Clark; T J Meyer; N W Pearlman
Journal:  Arch Intern Med       Date:  1984-12

8.  Protective effect of organic cation transport inhibitors on cis-diamminedichloroplatinum-induced nephrotoxicity.

Authors:  J E Bird; M M Walser; A J Quebbemann
Journal:  J Pharmacol Exp Ther       Date:  1984-12       Impact factor: 4.030

9.  "Two-route chemotherapy" using high-dose ip cisplatin and iv sodium thiosulfate, its antidote, for peritoneally disseminated cancer in mice.

Authors:  Y Iwamoto; T Kawano; J Uozumi; K Aoki; T Baba
Journal:  Cancer Treat Rep       Date:  1984-11

10.  Effects of cisplatin on different measures of glomerular function in the human kidney with special emphasis on high-dose.

Authors:  G Daugaard; N Rossing; M Rørth
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333
View more
  44 in total

1.  Synthesis, characterization, and photophysical properties of three platinum(II) complexes bearing fluorescent analogues of the Di-2-pyridylmethane ligand.

Authors:  Justin J Wilson; Juliana Fedoce Lopes; Stephen J Lippard
Journal:  Inorg Chem       Date:  2010-06-07       Impact factor: 5.165

Review 2.  Synthetic methods for the preparation of platinum anticancer complexes.

Authors:  Justin J Wilson; Stephen J Lippard
Journal:  Chem Rev       Date:  2013-11-27       Impact factor: 60.622

3.  Prevention of Cisplatin-Induced Acute Kidney Injury: A Systematic Review and Meta-Analysis.

Authors:  Aghilès Hamroun; Rémi Lenain; Jean Joel Bigna; Elodie Speyer; Linh Bui; Paul Chamley; Nicolas Pottier; Christelle Cauffiez; Edmone Dewaeles; Xavier Dhalluin; Arnaud Scherpereel; Marc Hazzan; Mehdi Maanaoui; François Glowacki
Journal:  Drugs       Date:  2019-09       Impact factor: 9.546

4.  Synthesis, characterization, and cytotoxicity of platinum(IV) carbamate complexes.

Authors:  Justin J Wilson; Stephen J Lippard
Journal:  Inorg Chem       Date:  2011-03-01       Impact factor: 5.165

5.  Safety of a short hydration method for cisplatin administration in comparison with a conventional method-a retrospective study.

Authors:  Emiko Sakaida; Shunichiro Iwasawa; Ryota Kurimoto; Takahiro Ebata; Chiaki Imai; Tomoko Oku; Ikuo Sekine; Yuji Tada; Koichiro Tatsumi; Yuichi Takiguchi
Journal:  Jpn J Clin Oncol       Date:  2016-01-10       Impact factor: 3.019

6.  Phospholipase A2 inhibits cisplatin-induced acute kidney injury by modulating regulatory T cells by the CD206 mannose receptor.

Authors:  Hyunseong Kim; Hyojung Lee; Gihyun Lee; Hyunil Jang; Sung-Su Kim; Heera Yoon; Geun-Hyung Kang; Deok-Sang Hwang; Sun Kwang Kim; Hwan-Suck Chung; Hyunsu Bae
Journal:  Kidney Int       Date:  2015-05-20       Impact factor: 10.612

Review 7.  A Systematic Review of Strategies to Prevent Cisplatin-Induced Nephrotoxicity.

Authors:  Daniel J Crona; Aimee Faso; Tomohiro F Nishijima; Kathleen A McGraw; Matthew D Galsky; Matthew I Milowsky
Journal:  Oncologist       Date:  2017-04-24

8.  Partial and complete de Toni-Debré-Fanconi syndrome after ifosfamide chemotherapy of childhood malignancy.

Authors:  R Rossi; J H Ehrich
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

9.  A phase I and pharmacology study of an oral platinum complex, JM216: dose-dependent pharmacokinetics with single-dose administration.

Authors:  M J McKeage; P Mistry; J Ward; F E Boxall; S Loh; C O'Neill; P Ellis; L R Kelland; S E Morgan; B Murrer
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

Review 10.  Nuclear medicine in the monitoring of organ function and the detection of injury related to cancer therapy.

Authors:  R A Valdés Olmos; C A Hoefnagel; J B van der Schoot
Journal:  Eur J Nucl Med       Date:  1993-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.